As the GoE initiative moves into its second phase, we are pleased to invite leading experts and opinion leaders in genomics, personalized medicine and public health to join an exclusive online roundtable discussion event. This high-level discussion aims to share the latest progress and emerging results of the Genome of Europe project, while creating a space for experts to reflect on real-world implementation experiences and future opportunities for genomics-driven healthcare in Europe.
Personalised invitations have been sent out by the GoE consortium to EU officials, national politicians and stakeholders, healthcare authorities, leading research experts of the filed and journalists. We hope to encourage our invited participants to take these insights forward within their own networks and communities and communicate GoE latest achievements and future prospects to a wider community.
Date: 15 April 2026
Time: 15:00 CET (duration ~75 minutes)
Format: Online roundtable discussion (by prior registration only)
Registration: Available upon personal invitation (If you have not received an invitation, but feel that you should be part of this event, please contact GoE consortium via our contact form)
The roundtable will feature an overview of the current state of Genome of Europe project and short expert perspectives on national initiatives and implementation pathways in personalised medicine:
Program
Genome of Europe: a multinational reference and beyond
Prof. Dr. André Uitterlinden (GoE project Lead)
Professor of Complex Genetics, Laboratory of Population Genomics, Department of Internal Medicine, Erasmus MC University Medical Center, Netherlands
André G. Uitterlinden is an emeritus Professor of Complex Genetics and was with > 50 group members head of the Laboratory of Population Genomics and the genomics facility at the Erasmus Medical Centre in Rotterdam. Prof. Uitterlinden has a long standing interest in DNA analysis, both technically as well as applying this to human health related research.
PROPHET- Personalized Prevention Roadmap for the future healthcare.
Prof. Stefania Boccia
Professor of Hygiene, Preventive Medicine and Public Health at Università Cattolica del Sacro Cuore, Italy
Prof. Stefania Boccia is a Full Professor of Hygiene, Preventive Medicine and Public Health and serves as the Director of the Department of Life Sciences and Public Health at the Università Cattolica del Sacro Cuore in Rome. Her academic and scientific work spans epidemiology, personalized medicine, and healthcare policy, with a strong international footprint. She also holds key leadership roles in major European public health initiatives and expert groups, and is recognized among the world’s top 2% scientists in public health
Genomics for Poland (G4PL) – project outline and relation to Genome of Europe
Prof. Luiza Handschuh
Director of Institute of Bioorganic Chemistry Polish Academy of Sciences, Head of Laboratory of Genomics, Poland
Luiza Handschuh is a molecular biologist, specialized in genomics and transcriptomics, particularly interested in human genomics, oncogenomics, and archaeogenomics. Co-organizer of the European Center for Bioinformatics and Genomics (ECBiG) and the Poznan Center for Archaeogenomics (PCA). She is responsible for implementing microarray and next-generation sequencing (NGS) technologies at the Institute of Bioorganic Chemistry Polish Academy of Sciences (IBCH PAS). In the time of COVID-19 pandemic, she was a coordinator of the ‘Viral Support Group’, a group of volunteers from IBCH PAS actively involved in COVID-19 diagnostics and commercialization of the Polish SARS-CoV-2 diagnostic test. Since 2013 she is the head of the Laboratory of Genomics and since December 2023 – director of IBCH PAS. She is a participant in the Genome of Europe and leader of the G4PL – Genomics for Poland project; Polish expert in the EU Cancer Mission; a member of the European Society of Human Genetics, the Human Genome Organization, the Polish Society of Hematology and Transfusion Medicine, and the Polish Biochemical Society.
Beyond One-Size-Fits-All: Implementing Population-Based Personalised Breast Cancer Screening in Estonia
Krista Kruuv-Käo
Healthcare Services Development Manager at the Estonian Health Insurance Fund
Krista Kruuv‑Käo is a former medical doctor with a long‑standing background in personalised medicine and public health. She played a significant role in the early development of the Estonian Biobank and has gained industry experience through her work with Antegenes, where she contributed to the advancement of genetic‑based risk assessment and personalised cancer prevention services. Today, Krista Kruuv‑Käo leads healthcare service development at the Estonian Health Insurance Fund (Tervisekassa), serving as the head of preventive services and playing a central role in the rollout of nationwide cancer screening programs and the integration of genetic data into public health services.
Pharmacogenomics in Netherlands
Prof. Dr. Jesse Swen (PhD, PharmD)
Professor of Clinical Pharmacy & Section Chair of the Laboratory at the Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Netherlands
Jesse Swen is a leading pharmacogenomics researcher and full professor of clinical pharmacy, specializing in translational pharmacogenetics at the Leiden University Medical Center (LUMC). His work focuses on improving drug treatment outcomes through the discovery and clinical implementation of pharmacogenetic biomarkers.
Followed by an open discussion session…
Data Privacy Notice of GoE Roundtable discussion event